Page 239

DRUG DEVELOPMENT

10:45 a.m. Regulatory Requirements Affecting Marijuana
J. Richard Crout, Crout Consulting

11:15 a.m. Marinol and the Market
Robert E. Dudley, Unimed Pharmaceuticals, Inc.

11:45 a.m. Development of Cannabis-based Therapeutics
Dave Pate, HortaPharm, B.V.

12:15 p.m. LUNCH

DRUG DELIVERY

1:30 p.m.  Alternative Drug Delivery Technologies for the Therapeutic Use of Marijuana
Phyllis I. Gardner, ALZA Corporation, Stanford University

2:00 p.m.  Delivery of Analgesics via the Respiratory Track
Reid M. Rubsamen, Aradigm Corporation

2:30 p.m.  Current Concepts for Delivery of THC
Mahendra G. Dedhiya, Roxanne Laboratories, Inc.

3:00 p.m.  D9-THC-Hemisuccinate in Suppository Formulation: An Alternative to Oral and Smoked
THC Mahmoud A. ElSohly, University of Mississippi, ElSohly Laboratories, Inc.

3:30 p.m. Concluding Remarks
John A. Benson, Jr., IOM Study Investigator, Oregon Health Sciences University

3:45 p.m. ADJOURN



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement